PH.D Fengrong He Won the 2million Project Funding in the Yellow Crane Associate Program
According to the decision of the talent work leading group of Wuhan Economic and Technological Development Zone, about the 13 high-level talents including Mr. Zhang Guoguang are chosen in the “Yellow Crane Associate Program”, that PH.D Ferong He in our company won the 2 million project funding in this campaign with the project of “antigenicity re-election and R&D of the detection method for the small molecular hapten”. This reward, is not only the affirmation of the government for our company’s years of continuous R&D work, certainly also spur us continue to walk the road of innovation, firmly. We will make persistent efforts, carry forward inno......
Establishment of Cloud-Clone Diagnostic Reagents Institute
Cloud-Clone Diagnostic Reagents Institute was formally established. It was located in the Zhenhua Road, covers an area of 10 mu. Now, the building area with 2760 square meters used for the production workshop of the clinical diagnostic reagents of GMP. And, the R&D building which was newly built with about 10000 square meters, mainly used for the research and development of the new technology of the diagnostic reagents.
USCN attended the 9th Biennial Meeting of Chinese Society for immunology
Uscn Life Science Inc.attended the 9th Biennial Meeting of ChineseSociety for immunology on October 18-21, 2014, at JinanShandongHotel, Ji'nan, China.This conference was hosted by CSI(Chinese Society for Immunology) and Shandong Society for Immunology,is an national academicevent. As the highestacademic meetingin Chinese immunology field, this conferencereceived over 1536 papers. 26 top-ranking immunologistsat home and abroad were invited to speak at the conference,scientific researchers exchanged the latest achievements of the world, promoted the development of immunologyinchina. During the meeting,our company exhibitedour main products on the A19exhibition booth,meta large nu......
USCN Won the Class A Qualification Certificate Issued By the Customs
Approved by the general administration of customs, the level of customs classification of USCN upgraded to A class from Sep. 3, 2014. And get a class A qualification certificate issued by the customs. For our company, the class A qualification is not only the affirmation of the customs for our legal and orderly operation, but more importantly, we can do customs clearance from the rapid channel, and can enjoy many preferential polices of customs. And this will have positive effect on improving the shipment clearance rate, and reducing the business operation cost.
USCN attended the 11th CSBMB Membership Congress and the National Academic Conference in 2014.
In Aug 21-23, Uscn Life Science Inc. attended the 11th Chinese Society of Biochemistry and Molecular Biology Membership Congress and the National Academic Conference in 2014. The theme of the conference fouces on dynamic biochemistry, which included the function and distribution of protein, drug screening, young scientist Forum, etc. This conference was held in the International Conference Center of Xiamen, it was a grand meeting for domestic researchers in Biochemistry and Molecular Biology. About 1,500 elite researchers had participated in the conference. Also there were a lot of famous biological enterprises from home and abroad, such as GE, Thermo, Merck-Millipore, Abcam and so ......
USCN was invited to visit a number of famous U.S. biotech companies
June 25- June 26, 2014, Chief Engineer of USCN, Jing Wang, together with CEO of CLOUD-CLONG, were invited to visit a number of U.S. biotech companies. First of all they visited 'MyBioSource, INC located in San Diego and held meeting with the company representative, Cindy and technician, Kristina Beiswenger, PhD to discuss product promotion and further cooperation. Both sides were very confident on future development. Mr. Wang also visited the world's leading manufacturer of primary cells, ScienCell Research Laboratories, at the invitation of their chairman, James J.Shen, PhD. USCN representatives visited the entire chain of primary cells at their production base and R&a......